Stockreport

Mirum doubles down on diversified rare disease strategy [Yahoo! Finance]

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report
PDF Rare disease companies often focus on developing just a few products — or even only one — before they're ultimately acquired. “Over the past handful of years now, the [Read more]